Deciphera Pharmaceuticals (DCPH) Earnings
|
Expand Research on DCPH
| Next EPS Date | 5/1/24 | EPS Growth Rate | +8.3% |
|---|---|---|---|
| Average EPS % Beat Rate | +4.9% | Revenue Growth Rate | +37.7% |
| Average % Move 1-Wk after EPS | +10.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/4/22 | Q222 | -$0.60 | -$0.66 | +$0.06 | $32.5M | $30.58M | N/A |  | | Details | |
10/30/23  |
Q323 | -$0.58 | -$0.61 | +$0.03 | $43.31M | $39.44M | N/A | | | Details | |
| 2/8/22 |  |
Q421 | -$1.51 | -$1.33 | -$0.18 | $24.2M | $23.29M | N/A | | | Details |
| 8/3/21 | |
Q221 | -$1.21 | -$1.15 | -$0.06 | $22M | $22M | N/A | | | Details |
| 8/9/23 | Q223 | -$0.57 | -$0.62 | +$0.05 | $38.3M | $36.1M | N/A | | | Details | |
| 11/2/21 | |
Q321 | -$1.37 | -$1.28 | -$0.09 | $23.2M | $23.36M | N/A | | | Details |
| 2/9/21 | |
Q420 | -$1.10 | -$1.15 | +$0.05 | $19.5M | $18.93M | N/A | | | Details |
| 3/9/20 | |
Q419 | -$1.31 | -$1.18 | -$0.13 | N/A | $1.15M | N/A | | | Details |
